Patients with Type 2 Diabetes Mellitus in the Czech Republic - Estimating Prevalence Based on Consumption of Pharmaceuticals and Their Costs
Abstract
Type 2 diabetes mellitus is a widespread disease which represents a serious medical and economic burden worldwide. We aim to analyze prevalence of type 2 diabetes mellitus in the Czech Republic using individual data on consumption of pharmaceuticals and to estimate costs incurred by these patients covered by the statutory health insurance.
Prevalence of diabetes in the Czech Republic based on consumption of pharmaceuticals has been growing since 2009. It reached 5.8% in 2015 and is higher among men than women (5.96% versus 5.65%).
Average public annual medical costs of a patient with type 2 diabetes were CZK 53 thousand in 2015. Total costs of patients with diabetes were CZK 33 billion in 2015, which represents 13% of all healthcare costs covered by the statutory health insurance.